EFFECT OF ONE BOOSTER DOSE IN ANTIRABIES VACCINATION

被引：1

作者：

LEMOS, HN

DESOUZA, MM

DECAMPOS, HHV

DEABREU, VLV

SOARES, ICG

REIS, W

机构：

[1] Laboratório de Raiva do Departamento de Virologia do Instituto de Microbiologia, Centro de Ciências de Saúde, Universidade Federal do Rio de Janeiro

来源：

BIOLOGICALS | 1992年 / 20卷 / 03期

关键词：

D O I：

10.1016/S1045-1056(05)80035-1

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

The antibody response obtained after one booster dose of rabies vaccine prepared in suckling mice brains at Serviço de Saúde Pública da Cidade do Rio de Janeiro is described. Four prime vaccinal groups were used: group I, persons who had received 16 doses 10 years before this investigation; group II, persons who had received 5 doses of the vaccine 10 years before; group III, persons who had received 9 doses 5 years before; and group IV, persons who had received 16 doses 5 years before. One booster dose of the vaccine was administered to all persons involved in the study. Blood samples were collected before vaccination (day 0), then 7 and 30 days after vaccination. Antibody titres were determined by seroneutralization test in mice (SWM).1 The results demonstrated that all persons who had been treated with 5, 9 or 16 doses of the vaccine 5 to 10 years before had their antibody titres increased on the 7th and 30th days after one booster dose. © 1992 The International Association of Biological Standardization.

引用

页码：171 / 175

页数：5

共 12 条

[1] INTRADERMAL IMMUNIZATION WITH HUMAN-DIPLOID CELL RABIES VACCINE - SEROLOGICAL AND CLINICAL-RESPONSES OF PERSONS WITH AND WITHOUT PRIOR VACCINATION WITH DUCK EMBRYO VACCINE [J].

BURRIDGE, MJ ;

BAER, GM ;

SUMNER, JW ;

SUSSMAN, O .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (13) :1611-1614

[2] 2-YEAR COMPARATIVE TRIAL ON THE IMMUNOGENICITY AND ADVERSE-EFFECTS OF PURIFIED CHICK-EMBRYO CELL RABIES VACCINE FOR PRE-EXPOSURE IMMUNIZATION [J].

DREESEN, DW ;

FISHBEIN, DB ;

KEMP, DT ;

BROWN, J .

VACCINE, 1989, 7 (05) :397-400

[3]

FLUENZALIDA E, 1955, BIOL I BACTERIOL, V8, P3

[4]

GOMES MCC, 1978, REV MUN MED, V1, P10

[5]

GREENBERG M, 1960, JAMA-J AM MED ASSOC, V172, P333

[6]

HABEL K, 1973, LABORATORY TECHNIQUE, P266

[7] NEUROLOGIC COMPLICATIONS OF SEMPLE-TYPE RABIES VACCINE - CLINICAL AND IMMUNOLOGICAL STUDIES [J].

HEMACHUDHA, T ;

PHANUPHAK, P ;

JOHNSON, RT ;

GRIFFIN, DE ;

RATANAVONGSIRI, J ;

SIRIPRASOMSUP, W .

NEUROLOGY, 1987, 37 (04) :550-556

[8]

REED L. J., 1938, AMER JOUR HYG, V27, P493

[9] PERSISTENCE OF RABIES ANTIBODY 5 YEARS AFTER PREEXPOSURE PROPHYLAXIS WITH HUMAN-DIPLOID CELL ANTIRABIES VACCINE AND ANTIBODY-RESPONSE TO A SINGLE BOOSTER DOSE [J].

RODRIGUES, FM ;

MANDKE, VB ;

ROUMIANTZEFF, M ;

RAO, CVRM ;

MEHTA, JM ;

PAVRI, KM ;

POONAWALLA, C .

EPIDEMIOLOGY AND INFECTION, 1987, 99 (01) :91-95

[10]

SOUZA MM, 1980, THESIS U FEDERAL RIO

← 1 2 →